Event Type
Disclosure
Mandatory
Variant
8-K
. The information in Item 2.02 of this Current Report on Form 8-K is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the
of this Current Report on Form 8-K, including the accompanying Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange A
Other Events. On January 8, 2026, the Company reported its progress across its portfolio of RNA-based therapeutics for the treatment of neuromuscular and ocular
Financial Statements and Exhibits. (d) Exhibits. The following exhibit relating to Item 7.01 of this Form 8-K shall be deemed to be furnished and not filed: 99.